Showing Results for: “diabetes”

Largest-Study-of-its-Kind Uncovers Potential Underlying Condition for People with Difficult-to-Control Type 2 Diabetes and Need for Improved Screening and Treatment Approaches Today, findings from the CATALYST study reveal that hypercortisolism may be a significant factor for why type 2 diabetes (T2D) remains difficult to control for many patients. This study found that 24% of individuals with difficult-to-control type 2 diabetes have hypercortisolism, a condition characterized by high cortisol levels. The results were presented as a late-breaking symposium today at the 84th Scientific

The American Diabetes Association ® (ADA) welcomes Rita Rastogi Kalyani, MD, MHS, whose appointment as its new chief scientific and medical officer was previously announced, as she begins her tenure at the organization. In this role, Dr. Kalyani will lead the ADA’s efforts in diabetes prevention, health care improvement, research and science, nutrition and wellness, and obesity education and prevention. Her work will also encompass community engagement and diabetes self-management education as part of the ADA’s mission to prevent and cure diabetes and to improve the lives of all people

Tracey D. Brown, Chief Executive Officer of the American Diabetes Association (ADA), issued the following statement in response to the unprecedented number of Members of Congress who invited people living with diabetes to join them at President Donald J. Trump’s State of the Union address: “Tonight, at least 13 Members of Congress will host their constituents that are living with diabetes, and who represent the seven million Americans dependent on insulin, at the State of the Union address. They will elevate the voices of all people with diabetes and their families, many of whom struggle to

A new consensus report addressing the benefits, challenges, and recommendations related to automated insulin delivery (AID) is being jointly published today by two leading diabetes organizations: the American Diabetes Association ® (ADA) and the European Association for the Study of Diabetes (EASD). The ADA and the EASD convened a joint Diabetes Technology Working Group to review the current landscape of AID systems and recommend targeted actions. “The report addresses the clinical usage of AID systems from a practical point of view rather than as a meta-analysis or a review of all relevant

Cycling event raises funds to support diabetes research, local programming, and advocacy efforts On May 2, the American Diabetes Association ® (ADA) will host its 2026 Tour de Cure ®: Pacific Northwest. This cycling fundraiser will bring together individuals, families, organizations, and corporations for a ride in support of people living with diabetes. Time and date: May 2 from 7:00 a.m.–2:00 p.m. Location: The Park at Bothell Landing, 9919 NE 180th St., Bothell, WA 98011 Register, join a team, and fundraise: tour.diabetes.org/731 “As spring brings a renewed sense of energy and connection

Cycling event raises funds to support diabetes research, local programming, and advocacy efforts On April 25, the American Diabetes Association ® (ADA) will host its 2026 Tour de Cure ®: Mid-Atlantic. This cycling fundraiser will bring together individuals, families, organizations, and corporations for a ride in support of people living with diabetes. Time and date: Saturday, April 25 with registration open at 6:30 a.m. Start times vary per route. Location: Windsor Castle Park, 705 Cedar St, Smithfield, VA 23430 Register, join a team, and fundraise: diabetes.org/MidAtlanticTour “We are excited

Head-to-head comparison of glucose-lowering medications helps inform individualized treatment strategies Today, investigators sponsored by the National Institutes of Health announced findings from the largest and longest study comparing the effectiveness of common medications to treat type 2 diabetes. Results of the GRADE study were presented at the virtual 81st Scientific Sessions of the American Diabetes Association (ADA). Controlling blood glucose levels over time is a major challenge for people with type 2 diabetes, a condition that disproportionally impacts Black and Hispanic people, who

The American Diabetes Association ® (ADA) is excited to announce the return to in-person ADA Camps for the Summer season of 2022, with staggered registration beginning on February 16, 2022. “Young people have gone through a lot during the pandemic, and the ADA knows it is vitally important to get children back to doing what they do best–meeting new friends and enjoying activities together in a safe environment,” said Charles D. Henderson, Chief Development Officer of the ADA. “Our ADA Camps offer a traditional summer camp experience, while giving children the chance to develop basic diabetes

By continuing to follow the cohort from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study sponsored by the National Institutes of Health (NIH), researchers can now report on the extensive development of severe renal, cardiac, eye, nerve, and pregnancy complications in early adulthood in patients with youth-onset type 2 diabetes. Results from this follow up study, TODAY2, presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions®, show an accelerating rate of serious complications within the last five years and point to the increased

Gary Dougherty, Director of State Government Affairs for the American Diabetes Association issued the following statement: The American Diabetes Association® (ADA) applauds Gov. Tony Evers’ call for a special session of the state legislature on Tuesday, May 25, 2021, to expand BadgerCare. The outcome of that session will have a tremendous impact on more than 90,000 lives of Wisconsinites who would become eligible for affordable health care coverage. Access to adequate and affordable health coverage is critically important for the more than 2.1 million Wisconsin residents living with or at risk